老虎證券

BRIEF-Allarity Therapeutics Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Reuters
04-01
BRIEF-Allarity <a href="https://laohu8.com/S/LENZ">Therapeutics</a> Cash & Cash Receivable Balance Of $20.9 Million As Of Dec 31, Expected To Fund Operations, Including Clinical Activities Into 2027

Allarity Therapeutics Inc ALLR.O:

  • ALLARITY THERAPEUTICS: CASH & CASH RECEIVABLE BALANCE OF $20.9 MILLION AS OF DEC 31, EXPECTED TO FUND OPERATIONS, INCLUDING CLINICAL ACTIVITIES INTO 2027

  • ALLARITY THERAPEUTICS: ENROLLMENT IN NEW PHASE 2 SCLC TRIAL TO BEGIN IN Q2-Q3 2025, FULLY FUNDED BY U.S. VETERANS ADMINISTRATION

Source text: ID:nGNX6nrXZ8

Further company coverage: ALLR.O

免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10